Follicum Competitors and Similar CompaniesClear all
MannKind Corporation's competitors and similar companies include Kadimastem.
 MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Kadimastem Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs). | |
Founding Date | Founding Date 1991 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Westlake Village, US HQ Danbury, US | Locations Ness Ziona, IL HQ |
Employees | Employees 39513% increase | Employees 11 |
Financial | ||
Revenue (est.) | Revenue (est.) $349m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $26.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $322.2m (FY, 2025) | Gross profit N/A |
Net income | Net income $5.9m (FY, 2025) | Net income (₪26.6m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Kadimastem
HQ
Ness Ziona, IL
Employees
11
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
View company